About Peter Finn
Peter Finn is a secretary at CeleCor Therapeutics.
Peter Finn first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Peter Finn in the role, so the role may have started earlier or lasted longer.
CeleCor Therapeutics, Inc.
Secretary
2017 – 2026 · Del Mar, CA
Develops an investigational drug for early treatment of severe heart attacks.
Key Colleagues at Startups
The people Peter Finn works with at each company, as listed on that company's latest Form D.
CeleCor Therapeutics, Inc. · Form D, Jul 9, 2026